HUP0201233A3 - Pharmaceutical composition in the form of granulate and its preparation by melt granulation - Google Patents

Pharmaceutical composition in the form of granulate and its preparation by melt granulation

Info

Publication number
HUP0201233A3
HUP0201233A3 HU0201233A HUP0201233A HUP0201233A3 HU P0201233 A3 HUP0201233 A3 HU P0201233A3 HU 0201233 A HU0201233 A HU 0201233A HU P0201233 A HUP0201233 A HU P0201233A HU P0201233 A3 HUP0201233 A3 HU P0201233A3
Authority
HU
Hungary
Prior art keywords
granulate
preparation
pharmaceutical composition
melt granulation
granulation
Prior art date
Application number
HU0201233A
Other languages
Hungarian (hu)
Original Assignee
Lek Tovarna Farmacevtskih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Tovarna Farmacevtskih filed Critical Lek Tovarna Farmacevtskih
Publication of HUP0201233A2 publication Critical patent/HUP0201233A2/en
Publication of HUP0201233A3 publication Critical patent/HUP0201233A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Liquid Deposition Of Substances Of Which Semiconductor Devices Are Composed (AREA)
  • Glanulating (AREA)
HU0201233A 1999-05-19 2000-05-18 Pharmaceutical composition in the form of granulate and its preparation by melt granulation HUP0201233A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI9900119A SI20244A (en) 1999-05-19 1999-05-19 Melt granulation

Publications (2)

Publication Number Publication Date
HUP0201233A2 HUP0201233A2 (en) 2002-08-28
HUP0201233A3 true HUP0201233A3 (en) 2003-10-28

Family

ID=20432471

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201233A HUP0201233A3 (en) 1999-05-19 2000-05-18 Pharmaceutical composition in the form of granulate and its preparation by melt granulation

Country Status (13)

Country Link
EP (1) EP1183013A2 (en)
AU (1) AU4969700A (en)
BG (1) BG106236A (en)
CZ (1) CZ20014133A3 (en)
EE (1) EE200100607A (en)
HR (1) HRP20010932A2 (en)
HU (1) HUP0201233A3 (en)
PL (1) PL351654A1 (en)
RU (1) RU2001134166A (en)
SI (1) SI20244A (en)
SK (1) SK16642001A3 (en)
WO (1) WO2000069415A2 (en)
YU (1) YU82001A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0109544A (en) * 2000-03-28 2003-06-10 Biochemie Gmbh Granules with hidden flavor
MXPA03003146A (en) * 2000-10-13 2004-12-06 Advancis Pharmaceuticals Extended release erythromycin derivatives.
PT1484056E (en) 2002-02-21 2013-10-14 Otsuka Pharma Co Ltd Sustained release preparations and process for producing the same
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2085342A1 (en) * 1990-06-14 1991-12-15 Milton R. Kaplan Stable aqueous drug suspensions
JP3265680B2 (en) * 1992-03-12 2002-03-11 大正製薬株式会社 Oral pharmaceutical composition
AU5681294A (en) * 1992-11-30 1994-06-22 Kv Pharmaceutical Company Tastemasked pharmaceutical materials
IT1312058B1 (en) * 1999-04-09 2002-04-04 Pharmaplus S R L METHOD FOR MICRO-ENCAPSULATION OF MEDICATIONS.

Also Published As

Publication number Publication date
RU2001134166A (en) 2003-08-27
AU4969700A (en) 2000-12-05
EP1183013A2 (en) 2002-03-06
SI20244A (en) 2000-12-31
HRP20010932A2 (en) 2003-04-30
HUP0201233A2 (en) 2002-08-28
SK16642001A3 (en) 2002-05-09
YU82001A (en) 2004-07-15
EE200100607A (en) 2003-02-17
WO2000069415A3 (en) 2001-04-26
WO2000069415A2 (en) 2000-11-23
PL351654A1 (en) 2003-05-19
CZ20014133A3 (en) 2002-03-13
BG106236A (en) 2002-08-30

Similar Documents

Publication Publication Date Title
HK1080724A1 (en) Stabilized pharmaceutical composition in lyophilized form
IL147533A0 (en) Novel quinuclidine derivatives and medicinal compositions containing the same
HUP0203190A3 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
IL145071A0 (en) Fused ring compounds and pharmaceutical compositions containing the same
GC0000307A (en) Pyrimidone compounds and pharmaceutical composition containing them
HUP0301325A3 (en) Stabilized pharmaceutically effective composition and pharmaceutical composition comprising the same and process for preparation the composition
IL148489A0 (en) Quinazoline compounds and pharmaceutical compositions containing them
PL351387A1 (en) Pharmaceutical composition
HUP0200548A2 (en) Pharmaceutical compositions and their use
HK1055739A1 (en) Novel quinuclidine derivatives and medicinal compositions containing the same
HUP0203325A3 (en) Bicyclic amino acids, pharmaceutical compositions containing them and their use
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
IL136251A0 (en) Soft pellet drug composition and methods for the preparation thereof
HUP0202329A2 (en) Pharmaceutical composition in unit form containing acetylsalycilic acid and clopidogrel hydrogenosulphate
AU7405000A (en) Melt granulated composition and modified release dosage form prepared from said composition
HUP0102419A3 (en) Melted and cast azs products and their employment
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
HUP0200088A3 (en) Pyridazin-3-one derivatives and pharmaceutical compositions containing the same
HUP0201233A3 (en) Pharmaceutical composition in the form of granulate and its preparation by melt granulation
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
HUP0104544A2 (en) New pharmaceutical composition and the process for its preparation
EP1235806A4 (en) Novel 5-pyrimidinecarboxamide derivatives and the pharmaceutical compositions containing said derivatives
HRP20020153B1 (en) Ciprofloxacin containing pharmaceutical composition and process for the preparation thereof
GB9923431D0 (en) Pharmaceutical compositions and their use